Tibulizumab Skin Healing and Inflammation Evaluation for Lasting Defense

NCT06993610 · clinicaltrials.gov ↗

PHASE2

Phase

RECRUITING

Status

225

Enrollment

INDUSTRY

Sponsor class

Conditions

Hidradenitis Suppurativa (HS)

Interventions

BIOLOGICAL: Tibulizumab Dose A
BIOLOGICAL: Tibulizumab Dose B
OTHER: Placebo

Sponsor

Zura Bio Inc